Coagulation Factor Concentrates Market: Global Market Estimation, Dynamics, Regional Share, Trends, Competitor Analysis 2017 to 2021 and Forecast 2022 to 2028

$ PRICE - $ 3,000.00$ 8,900.00

Coagulation Factor Concentrates Market: Type (Fibrinogen Concentrates, Prothrombin Complex Concentrates, Factor XIII Concentrates, Recombinant Activated Factor VIIa, Others), End User (Hospitals & Clinics, Research Laboratories, Academic Institutions, Others), and Geography

$ PRICE - $ 3,000.00$ 8,900.00
Clear selection
Clear
$ PRICE - $ 3,000.00$ 8,900.00
FacebookTwitterLinkedinEmail
SKU: N/A Category:

Report

Description

1. Executive Summary
2. Global Coagulation Factor Concentrates Market Introduction
2.1. Global Coagulation Factor Concentrates Market – Taxonomy
2.2. Global Coagulation Factor Concentrates Market –Definitions
2.2.1. Type
2.2.2. End User
2.2.3. Region
3. Global Coagulation Factor Concentrates Market Dynamics
3.1. Drivers
3.2. Restraints
3.3. Opportunities/Unmet Needs of the Market
3.4. Trends
3.5. Global Coagulation Factor Concentrates Market Dynamic Factors – Impact Analysis
3.6. Impact of COVID 19 on The Market
3.7. Three Forecast Scenarios – Pessimistic, Conservative, and Opportunistic
3.8. Mapping Market Player’s Activities
3.9. Recent Key Developments
3.10. Financial Status of the Market Players
3.11. Recent Acquisitions, Collaborations, and Mergers
4. Global Coagulation Factor Concentrates Market Analysis, 2017 – 2021 and Forecast, 2022 – 2028
4.1. Market Analysis, 2017 – 2021 and Forecast, 2022 – 2028 (Revenue, USD Million)
4.2. Year-over-Year (Y-o-Y) Growth Analysis (%)
4.3. Market Opportunity Analysis
5. Global Coagulation Factor Concentrates Market Forecast, By Type, 2017 – 2021 and Forecast, 2022 – 2028 (Revenue, USD Million)
5.1. Fibrinogen Concentrates
5.1.1. Market Analysis, 2017 – 2021 and Forecast, 2022 – 2028 (Revenue, USD Million)
5.1.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
5.1.3. Market Opportunity Analysis
5.2. Prothrombin Complex Concentrates
5.2.1. Market Analysis, 2017 – 2021 and Forecast, 2022 – 2028 (Revenue, USD Million)
5.2.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
5.2.3. Market Opportunity Analysis
5.3. Factor XIII Concentrates
5.3.1. Market Analysis, 2017 – 2021 and Forecast, 2022 – 2028 (Revenue, USD Million)
5.3.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
5.3.3. Market Opportunity Analysis
5.4. Recombinant Activated Factor VIIa
5.4.1. Market Analysis, 2017 – 2021 and Forecast, 2022 – 2028 (Revenue, USD Million)
5.4.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
5.4.3. Market Opportunity Analysis
5.5. Others
5.5.1. Market Analysis, 2017 – 2021 and Forecast, 2022 – 2028 (Revenue, USD Million)
5.5.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
5.5.3. Market Opportunity Analysis
6. Global Coagulation Factor Concentrates Market Forecast, By End User, 2017 – 2021 and Forecast, 2022 – 2028 (Revenue, USD Million)
6.1. Hospitals & Clinics
6.1.1. Market Analysis, 2017 – 2021 and Forecast, 2022 – 2028 (Revenue, USD Million)
6.1.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
6.1.3. Market Opportunity Analysis
6.2. Research Laboratories
6.2.1. Market Analysis, 2017 – 2021 and Forecast, 2022 – 2028 (Revenue, USD Million)
6.2.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
6.2.3. Market Opportunity Analysis
6.3. Academic Institutions
6.3.1. Market Analysis, 2017 – 2021 and Forecast, 2022 – 2028 (Revenue, USD Million)
6.3.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
6.3.3. Market Opportunity Analysis
6.4. Others
6.4.1. Market Analysis, 2017 – 2021 and Forecast, 2022 – 2028 (Revenue, USD Million)
6.4.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
6.4.3. Market Opportunity Analysis
7. Global Coagulation Factor Concentrates Market Forecast, By Region, 2017 – 2021 and Forecast, 2022 – 2028 (Revenue, USD Million)
7.1. North America
7.1.1. Market Analysis, 2017 – 2021 and Forecast, 2022 – 2028 (Revenue, USD Million)
7.1.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
7.1.3. Market Opportunity Analysis
7.2. Europe
7.2.1. Market Analysis, 2017 – 2021 and Forecast, 2022 – 2028 (Revenue, USD Million)
7.2.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
7.2.3. Market Opportunity Analysis
7.3. Asia-Pacific
7.3.1. Market Analysis, 2017 – 2021 and Forecast, 2022 – 2028 (Revenue, USD Million)
7.3.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
7.3.3. Market Opportunity Analysis
7.4. Latin America
7.4.1. Market Analysis, 2017 – 2021 and Forecast, 2022 – 2028 (Revenue, USD Million)
7.4.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
7.4.3. Market Opportunity Analysis
7.5. Middle East and Africa
7.5.1. Market Analysis, 2017 – 2021 and Forecast, 2022 – 2028 (Revenue, USD Million)
7.5.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
7.5.3. Market Opportunity Analysis
7.6. Global Coagulation Factor Concentrates Market – Opportunity Analysis Index, By Type, End User, and Region, 2022 – 2028
8. North America Coagulation Factor Concentrates Market Analysis, 2017 – 2021 and Forecast, 2022 – 2028 (Revenue, USD Million)
8.1. Type Analysis 2017 – 2021 and Forecast 2022 – 2028 by Revenue (USD Million), Y-o-Y Growth (%), and Market Share (%)
8.1.1. Fibrinogen Concentrates
8.1.2. Prothrombin Complex Concentrates
8.1.3. Factor XIII Concentrates
8.1.4. Recombinant Activated Factor VIIa
8.1.5. Others
8.2. End User Analysis 2017 – 2021 and Forecast 2022 – 2028 by Revenue (USD Million), Y-o-Y Growth (%) and Market Share (%)
8.2.1. Hospitals & Clinics
8.2.2. Research Laboratories
8.2.3. Academic Institutions
8.2.4. Others
8.3. Country Analysis 2017 – 2021 and Forecast 2022 – 2028 by Revenue (USD Million) Y-o-Y Growth (%) and Market Share (%)
8.3.1. U.S.
8.3.2. Canada
8.4. North America Coagulation Factor Concentrates Market – Opportunity Analysis Index, By Type, End User and Country, 2022 – 2028
8.5. North America Coagulation Factor Concentrates Market Dynamics – Trends
9. Europe Coagulation Factor Concentrates Market Analysis, 2017 – 2021 and Forecast, 2022 – 2028 (Revenue, USD Million)
9.1. Type Analysis 2017 – 2021 and Forecast 2022 – 2028 by Revenue (USD Million), Y-o-Y Growth (%), and Market Share (%)
9.1.1. Fibrinogen Concentrates
9.1.2. Prothrombin Complex Concentrates
9.1.3. Factor XIII Concentrates
9.1.4. Recombinant Activated Factor VIIa
9.1.5. Others
9.2. End User Analysis 2017 – 2021 and Forecast 2022 – 2028 by Revenue (USD Million), Y-o-Y Growth (%) and Market Share (%)
9.2.1. Hospitals & Clinics
9.2.2. Research Laboratories
9.2.3. Academic Institutions
9.2.4. Others
9.3. Country Analysis 2017 – 2021 and Forecast 2022 – 2028 by Revenue (USD Million) Y-o-Y Growth (%) and Market Share (%)
9.3.1. Germany
9.3.2. UK
9.3.3. France
9.3.4. Italy
9.3.5. Spain
9.3.6. Rest of Europe
9.4. Europe Coagulation Factor Concentrates Market – Opportunity Analysis Index, By Type, End User and Country, 2022 – 2028
9.5. Europe Coagulation Factor Concentrates Market Dynamics – Trends
10. Asia-Pacific Coagulation Factor Concentrates Market Analysis, 2017 – 2021 and Forecast, 2022 – 2028 (Revenue, USD Million)
10.1. Type Analysis 2017 – 2021 and Forecast 2022 – 2028 by Revenue (USD Million), Y-o-Y Growth (%), and Market Share (%)
10.1.1. Fibrinogen Concentrates
10.1.2. Prothrombin Complex Concentrates
10.1.3. Factor XIII Concentrates
10.1.4. Recombinant Activated Factor VIIa
10.1.5. Others
10.2. End User Analysis 2017 – 2021 and Forecast 2022 – 2028 by Revenue (USD Million), Y-o-Y Growth (%) and Market Share (%)
10.2.1. Hospitals & Clinics
10.2.2. Research Laboratories
10.2.3. Academic Institutions
10.2.4. Others
10.3. Country Analysis 2017 – 2021 and Forecast 2022 – 2028 by Revenue (USD Million) Y-o-Y Growth (%) and Market Share (%)
10.3.1. Japan
10.3.2. China
10.3.3. India
10.3.4. ASEAN
10.3.5. Rest of Asia-Pacific
10.4. Asia-Pacific Coagulation Factor Concentrates Market – Opportunity Analysis Index, By Type, End User and Country, 2022 – 2028
10.5. Asia-Pacific Coagulation Factor Concentrates Market Dynamics – Trends
11. Latin America Coagulation Factor Concentrates Market Analysis, 2017 – 2021 and Forecast, 2022 – 2028 (Revenue, USD Million)
11.1. Type Analysis 2017 – 2021 and Forecast 2022 – 2028 by Revenue (USD Million), Y-o-Y Growth (%), and Market Share (%)
11.1.1. Fibrinogen Concentrates
11.1.2. Prothrombin Complex Concentrates
11.1.3. Factor XIII Concentrates
11.1.4. Recombinant Activated Factor VIIa
11.1.5. Others
11.2. End User Analysis 2017 – 2021 and Forecast 2022 – 2028 by Revenue (USD Million), Y-o-Y Growth (%) and Market Share (%)
11.2.1. Hospitals & Clinics
11.2.2. Research Laboratories
11.2.3. Academic Institutions
11.2.4. Others
11.3. Country Analysis 2017 – 2021 and Forecast 2022 – 2028 by Revenue (USD Million) Y-o-Y Growth (%) and Market Share (%)
11.3.1. Brazil
11.3.2. Argentina
11.3.3. Rest of Latin America
11.4. Latin America Coagulation Factor Concentrates Market – Opportunity Analysis Index, By Type, End User and Country, 2022 – 2028
11.5. Latin America Coagulation Factor Concentrates Market Dynamics – Trends
12. Middle East and Africa Coagulation Factor Concentrates Market Analysis, 2017 – 2021 and Forecast, 2022 – 2028 (Revenue, USD Million)
12.1. Type Analysis 2017 – 2021 and Forecast 2022 – 2028 by Revenue (USD Million), Y-o-Y Growth (%), and Market Share (%)
12.1.1. Fibrinogen Concentrates
12.1.2. Prothrombin Complex Concentrates
12.1.3. Factor XIII Concentrates
12.1.4. Recombinant Activated Factor VIIa
12.1.5. Others
12.2. End User Analysis 2017 – 2021 and Forecast 2022 – 2028 by Revenue (USD Million), Y-o-Y Growth (%) and Market Share (%)
12.2.1. Hospitals & Clinics
12.2.2. Research Laboratories
12.2.3. Academic Institutions
12.2.4. Others
12.3. Country Analysis 2017 – 2021 and Forecast 2022 – 2028 by Revenue (USD Million) Y-o-Y Growth (%) and Market Share (%)
12.3.1. Saudi Arabia
12.3.2. GCC Countries
12.3.3. South Africa
12.3.4. Rest of MEA
12.4. MEA Coagulation Factor Concentrates Market – Opportunity Analysis Index, By Type, End User and Country, 2022 – 2028
12.5. MEA Coagulation Factor Concentrates Market Dynamics – Trends
13. Competition Landscape 
13.1. Strategic Dashboard of Top Market Players
13.2. Company Profiles (Introduction, Financial Analysis, Type Offerings, Key Developments, Strategies, and SWOT Analysis)
13.2.1. CSL Behring
13.2.2. Shire
13.2.3. Kedrion S.P.A.
13.2.4. Grifols
13.2.5. Baxter International Inc.
13.2.6. Octapharma
13.2.7. LFB
13.2.8. Novo Nordisk A/S
13.2.9. Biotest
13.2.10. Green Cross Corporation
13.2.11. Shanghai RAAS Blood Products
13.2.12. Sanquin
13.2.13. Bio Product Laboratory
13.2.14. Medscape
14. Research Methodology
15. Key Assumptions and Acronyms

Frequently Asked Questions

2021 is the base year and 2028 is the forecast year.

In our report, we provide 12-15 market players’ information into the report. However, based on the client’s request we will provide additional country and regional market players information as well.


Report

Company Profile

 

  • CSL Behring
  • Shire
  • Kedrion S.P.A.
  • Grifols
  • Baxter International Inc.
  • Octapharma
  • LFB
  • Novo Nordisk A/S
  • Biotest
  • Green Cross Corporation
  • Shanghai RAAS Blood Products
  • Sanquin
  • Bio Product Laboratory
  • Medscape

Description

1. Executive Summary
2. Global Coagulation Factor Concentrates Market Introduction
2.1. Global Coagulation Factor Concentrates Market – Taxonomy
2.2. Global Coagulation Factor Concentrates Market –Definitions
2.2.1. Type
2.2.2. End User
2.2.3. Region
3. Global Coagulation Factor Concentrates Market Dynamics
3.1. Drivers
3.2. Restraints
3.3. Opportunities/Unmet Needs of the Market
3.4. Trends
3.5. Global Coagulation Factor Concentrates Market Dynamic Factors – Impact Analysis
3.6. Impact of COVID 19 on The Market
3.7. Three Forecast Scenarios – Pessimistic, Conservative, and Opportunistic
3.8. Mapping Market Player’s Activities
3.9. Recent Key Developments
3.10. Financial Status of the Market Players
3.11. Recent Acquisitions, Collaborations, and Mergers
4. Global Coagulation Factor Concentrates Market Analysis, 2017 – 2021 and Forecast, 2022 – 2028
4.1. Market Analysis, 2017 – 2021 and Forecast, 2022 – 2028 (Revenue, USD Million)
4.2. Year-over-Year (Y-o-Y) Growth Analysis (%)
4.3. Market Opportunity Analysis
5. Global Coagulation Factor Concentrates Market Forecast, By Type, 2017 – 2021 and Forecast, 2022 – 2028 (Revenue, USD Million)
5.1. Fibrinogen Concentrates
5.1.1. Market Analysis, 2017 – 2021 and Forecast, 2022 – 2028 (Revenue, USD Million)
5.1.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
5.1.3. Market Opportunity Analysis
5.2. Prothrombin Complex Concentrates
5.2.1. Market Analysis, 2017 – 2021 and Forecast, 2022 – 2028 (Revenue, USD Million)
5.2.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
5.2.3. Market Opportunity Analysis
5.3. Factor XIII Concentrates
5.3.1. Market Analysis, 2017 – 2021 and Forecast, 2022 – 2028 (Revenue, USD Million)
5.3.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
5.3.3. Market Opportunity Analysis
5.4. Recombinant Activated Factor VIIa
5.4.1. Market Analysis, 2017 – 2021 and Forecast, 2022 – 2028 (Revenue, USD Million)
5.4.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
5.4.3. Market Opportunity Analysis
5.5. Others
5.5.1. Market Analysis, 2017 – 2021 and Forecast, 2022 – 2028 (Revenue, USD Million)
5.5.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
5.5.3. Market Opportunity Analysis
6. Global Coagulation Factor Concentrates Market Forecast, By End User, 2017 – 2021 and Forecast, 2022 – 2028 (Revenue, USD Million)
6.1. Hospitals & Clinics
6.1.1. Market Analysis, 2017 – 2021 and Forecast, 2022 – 2028 (Revenue, USD Million)
6.1.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
6.1.3. Market Opportunity Analysis
6.2. Research Laboratories
6.2.1. Market Analysis, 2017 – 2021 and Forecast, 2022 – 2028 (Revenue, USD Million)
6.2.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
6.2.3. Market Opportunity Analysis
6.3. Academic Institutions
6.3.1. Market Analysis, 2017 – 2021 and Forecast, 2022 – 2028 (Revenue, USD Million)
6.3.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
6.3.3. Market Opportunity Analysis
6.4. Others
6.4.1. Market Analysis, 2017 – 2021 and Forecast, 2022 – 2028 (Revenue, USD Million)
6.4.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
6.4.3. Market Opportunity Analysis
7. Global Coagulation Factor Concentrates Market Forecast, By Region, 2017 – 2021 and Forecast, 2022 – 2028 (Revenue, USD Million)
7.1. North America
7.1.1. Market Analysis, 2017 – 2021 and Forecast, 2022 – 2028 (Revenue, USD Million)
7.1.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
7.1.3. Market Opportunity Analysis
7.2. Europe
7.2.1. Market Analysis, 2017 – 2021 and Forecast, 2022 – 2028 (Revenue, USD Million)
7.2.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
7.2.3. Market Opportunity Analysis
7.3. Asia-Pacific
7.3.1. Market Analysis, 2017 – 2021 and Forecast, 2022 – 2028 (Revenue, USD Million)
7.3.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
7.3.3. Market Opportunity Analysis
7.4. Latin America
7.4.1. Market Analysis, 2017 – 2021 and Forecast, 2022 – 2028 (Revenue, USD Million)
7.4.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
7.4.3. Market Opportunity Analysis
7.5. Middle East and Africa
7.5.1. Market Analysis, 2017 – 2021 and Forecast, 2022 – 2028 (Revenue, USD Million)
7.5.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
7.5.3. Market Opportunity Analysis
7.6. Global Coagulation Factor Concentrates Market – Opportunity Analysis Index, By Type, End User, and Region, 2022 – 2028
8. North America Coagulation Factor Concentrates Market Analysis, 2017 – 2021 and Forecast, 2022 – 2028 (Revenue, USD Million)
8.1. Type Analysis 2017 – 2021 and Forecast 2022 – 2028 by Revenue (USD Million), Y-o-Y Growth (%), and Market Share (%)
8.1.1. Fibrinogen Concentrates
8.1.2. Prothrombin Complex Concentrates
8.1.3. Factor XIII Concentrates
8.1.4. Recombinant Activated Factor VIIa
8.1.5. Others
8.2. End User Analysis 2017 – 2021 and Forecast 2022 – 2028 by Revenue (USD Million), Y-o-Y Growth (%) and Market Share (%)
8.2.1. Hospitals & Clinics
8.2.2. Research Laboratories
8.2.3. Academic Institutions
8.2.4. Others
8.3. Country Analysis 2017 – 2021 and Forecast 2022 – 2028 by Revenue (USD Million) Y-o-Y Growth (%) and Market Share (%)
8.3.1. U.S.
8.3.2. Canada
8.4. North America Coagulation Factor Concentrates Market – Opportunity Analysis Index, By Type, End User and Country, 2022 – 2028
8.5. North America Coagulation Factor Concentrates Market Dynamics – Trends
9. Europe Coagulation Factor Concentrates Market Analysis, 2017 – 2021 and Forecast, 2022 – 2028 (Revenue, USD Million)
9.1. Type Analysis 2017 – 2021 and Forecast 2022 – 2028 by Revenue (USD Million), Y-o-Y Growth (%), and Market Share (%)
9.1.1. Fibrinogen Concentrates
9.1.2. Prothrombin Complex Concentrates
9.1.3. Factor XIII Concentrates
9.1.4. Recombinant Activated Factor VIIa
9.1.5. Others
9.2. End User Analysis 2017 – 2021 and Forecast 2022 – 2028 by Revenue (USD Million), Y-o-Y Growth (%) and Market Share (%)
9.2.1. Hospitals & Clinics
9.2.2. Research Laboratories
9.2.3. Academic Institutions
9.2.4. Others
9.3. Country Analysis 2017 – 2021 and Forecast 2022 – 2028 by Revenue (USD Million) Y-o-Y Growth (%) and Market Share (%)
9.3.1. Germany
9.3.2. UK
9.3.3. France
9.3.4. Italy
9.3.5. Spain
9.3.6. Rest of Europe
9.4. Europe Coagulation Factor Concentrates Market – Opportunity Analysis Index, By Type, End User and Country, 2022 – 2028
9.5. Europe Coagulation Factor Concentrates Market Dynamics – Trends
10. Asia-Pacific Coagulation Factor Concentrates Market Analysis, 2017 – 2021 and Forecast, 2022 – 2028 (Revenue, USD Million)
10.1. Type Analysis 2017 – 2021 and Forecast 2022 – 2028 by Revenue (USD Million), Y-o-Y Growth (%), and Market Share (%)
10.1.1. Fibrinogen Concentrates
10.1.2. Prothrombin Complex Concentrates
10.1.3. Factor XIII Concentrates
10.1.4. Recombinant Activated Factor VIIa
10.1.5. Others
10.2. End User Analysis 2017 – 2021 and Forecast 2022 – 2028 by Revenue (USD Million), Y-o-Y Growth (%) and Market Share (%)
10.2.1. Hospitals & Clinics
10.2.2. Research Laboratories
10.2.3. Academic Institutions
10.2.4. Others
10.3. Country Analysis 2017 – 2021 and Forecast 2022 – 2028 by Revenue (USD Million) Y-o-Y Growth (%) and Market Share (%)
10.3.1. Japan
10.3.2. China
10.3.3. India
10.3.4. ASEAN
10.3.5. Rest of Asia-Pacific
10.4. Asia-Pacific Coagulation Factor Concentrates Market – Opportunity Analysis Index, By Type, End User and Country, 2022 – 2028
10.5. Asia-Pacific Coagulation Factor Concentrates Market Dynamics – Trends
11. Latin America Coagulation Factor Concentrates Market Analysis, 2017 – 2021 and Forecast, 2022 – 2028 (Revenue, USD Million)
11.1. Type Analysis 2017 – 2021 and Forecast 2022 – 2028 by Revenue (USD Million), Y-o-Y Growth (%), and Market Share (%)
11.1.1. Fibrinogen Concentrates
11.1.2. Prothrombin Complex Concentrates
11.1.3. Factor XIII Concentrates
11.1.4. Recombinant Activated Factor VIIa
11.1.5. Others
11.2. End User Analysis 2017 – 2021 and Forecast 2022 – 2028 by Revenue (USD Million), Y-o-Y Growth (%) and Market Share (%)
11.2.1. Hospitals & Clinics
11.2.2. Research Laboratories
11.2.3. Academic Institutions
11.2.4. Others
11.3. Country Analysis 2017 – 2021 and Forecast 2022 – 2028 by Revenue (USD Million) Y-o-Y Growth (%) and Market Share (%)
11.3.1. Brazil
11.3.2. Argentina
11.3.3. Rest of Latin America
11.4. Latin America Coagulation Factor Concentrates Market – Opportunity Analysis Index, By Type, End User and Country, 2022 – 2028
11.5. Latin America Coagulation Factor Concentrates Market Dynamics – Trends
12. Middle East and Africa Coagulation Factor Concentrates Market Analysis, 2017 – 2021 and Forecast, 2022 – 2028 (Revenue, USD Million)
12.1. Type Analysis 2017 – 2021 and Forecast 2022 – 2028 by Revenue (USD Million), Y-o-Y Growth (%), and Market Share (%)
12.1.1. Fibrinogen Concentrates
12.1.2. Prothrombin Complex Concentrates
12.1.3. Factor XIII Concentrates
12.1.4. Recombinant Activated Factor VIIa
12.1.5. Others
12.2. End User Analysis 2017 – 2021 and Forecast 2022 – 2028 by Revenue (USD Million), Y-o-Y Growth (%) and Market Share (%)
12.2.1. Hospitals & Clinics
12.2.2. Research Laboratories
12.2.3. Academic Institutions
12.2.4. Others
12.3. Country Analysis 2017 – 2021 and Forecast 2022 – 2028 by Revenue (USD Million) Y-o-Y Growth (%) and Market Share (%)
12.3.1. Saudi Arabia
12.3.2. GCC Countries
12.3.3. South Africa
12.3.4. Rest of MEA
12.4. MEA Coagulation Factor Concentrates Market – Opportunity Analysis Index, By Type, End User and Country, 2022 – 2028
12.5. MEA Coagulation Factor Concentrates Market Dynamics – Trends
13. Competition Landscape 
13.1. Strategic Dashboard of Top Market Players
13.2. Company Profiles (Introduction, Financial Analysis, Type Offerings, Key Developments, Strategies, and SWOT Analysis)
13.2.1. CSL Behring
13.2.2. Shire
13.2.3. Kedrion S.P.A.
13.2.4. Grifols
13.2.5. Baxter International Inc.
13.2.6. Octapharma
13.2.7. LFB
13.2.8. Novo Nordisk A/S
13.2.9. Biotest
13.2.10. Green Cross Corporation
13.2.11. Shanghai RAAS Blood Products
13.2.12. Sanquin
13.2.13. Bio Product Laboratory
13.2.14. Medscape
14. Research Methodology
15. Key Assumptions and Acronyms

ASIA PACIFIC OFFICE

Precision Business Insights, MIG 366, SAI PLAZA, 1st Floor, KPHB Colony, Hyderabad - 500072

EUROPE OFFICE

Precision Business Insights, Kemp House, 152 – 160 City Road, London EC1V 2NX